Navigation Links
Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study

A new study supports earlier estimates of the prevalence of bipolar disorder in the U.S. population, and suggests the illness may be more accurately characterized as a spectrum disorder. It also finds that many people with the illness are not receiving appropriate treatment. The study, published in the issue of Archives of General Psychiatry, analyzed data from the National Comorbidity Survey Replication (NCS-R), a nationwide survey of mental disorders among 9,282 Americans ages 18 and older.

NIMH researcher Kathleen Merikangas, Ph.D. and colleagues identified prevalence rates of three subtypes of bipolar spectrum disorder among adults. Bipolar I is considered the classic form of the illness, in which a person experiences recurrent episodes of mania and depression. People with bipolar II experience a milder form of mania called hypomania that alternates with depressive episodes. People with bipolar disorder not otherwise specified (BD-NOS), sometimes called subthreshold bipolar disorder, have manic and depressive symptoms as well, but they do not meet strict criteria for any specific type of bipolar disorder noted in the Diagnostic and Statistical Manual for Mental Disorders (DSM-IV), the reference manual for psychiatric disorders. Nonetheless, BD-NOS still can significantly impair those who have it.

The results indicate that bipolar I and bipolar II each occur in about 1 percent of the population; BD-NOS occurs in about 2.4 percent of the population. The findings support international studies suggesting that, given its multi-dimensional nature, bipolar disorder may be better characterized as a spectrum disorder.

"Bipolar disorder can manifest itself in several different ways. But regardless of type, the illness takes a huge toll," said NIMH Director Thomas R. Insel, M.D. "The survey's findings reiterate the need for a more refined understanding of bipolar symptoms, so we can better target treatment."

Mos
'"/>




Page: 1 2 3

Related medicine news :

1. Psychosocial Disability Varies In Accordance With Bipolar Symptom Changes
2. Seroquel to Treat Depression In Case Of Bipolar Disorder
3. Researchers Identify Gene Connected To Bipolar Disorder
4. Bipolar Risk Gene Identified
5. Mood Stabilizing drugs for Bipolar disorder
6. Bipolar Disorder Not Being Accurately Diagnosed By Doctors In UK
7. Promising Care Model For Bipolar Disorder
8. Research on Bipolar Disorder Launched
9. Is Extreme Irritability - a Childhood Bipolar Disorder?
10. Antidepressant Medication Has No Effect on Bipolar Patients
11. Intensive Psychotherapy Effective in Treating Bipolar Disorder

Post Your Comments:
(Date:12/2/2009)...LE, Tenn., Dec. 2 TeamHealth ( www...t Florida with the acquisition of Naples-based Eme...uary 2002, EPN has held an exclusive contract with...lities at the Downtown Naples Hospital, North Napl...also provides the staffing for two stand-alone urg...
(Date:12/2/2009)...he official congress of the European Association o...he European Society of Cardiology, where technique...nted. , New case reports will be presented at t...lighting the role of this new technology. , Now...s, it is likely that non-invasive imaging will gai...
(Date:12/2/2009)... Revolutionary new cell phones that direct mi...be available in early 2010 from Aerius Internation...er 2, 2009 -- Revolutionary new cell phones that d...rs will be available in early 2010 from Aerius Int...d with a Green Technology Award in wireless commun...
(Date:12/2/2009)... Dec. 2 The American He... Directors today announced Alan F. Dowling, PhD, w...er health information management (HIM) leader. Dr...e includes academia, systems management, strategic...rofit executive leadership. He is scheduled to ta...
(Date:12/2/2009)...Today,s Washington Post Highlights Dangers ...- If the Catholic bishops have their way, many ...ke for granted may be under threat. The pressure ...bate over healthcare reform has been widely report...s of the likely impact if that pressure to influen...
Breaking Medicine News(10 mins):Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Media alert: EUROECHO 2009 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2
...Products offer biologically safe water through poi...on, NEW YORK, June 3 Nephros, Inc., a medical,de...biting its Dual Stage,Ultrafilter products at the ...ss of the Nephros online,hemodiafiltration technol...
..., N.J., June 3 BD (Becton,Dickinson and Company) ...,announced today that it would present at the Gold...nference on Wednesday, June 11, 2008, at 4:20,p.m....r replay,through Wednesday, June 18, 2008., BD, a...
...N.J., June 3 HLTH Corporation,(Nasdaq: HLTH ) to...e,agreement to sell its ViPS segment to General Dy...d subsidiary of General Dynamics Corporation,(NYSE...d under the Hart-Scott-Rodino Act., ViPS provides...
...ells can produce tiny magnetic nuggets after the i...ists have found. The gene MagA could become a valu... body via magnetic resonance imaging (MRI), says X...to make mammalian cells have a magnetic signature,...
...., June 3 MedAmerica reports 2007 was its,17th co...sults. In,addition, MedAmerica outperformed the lo...years with a compound annual sales rate of 10%. (L...America,Insurance Company of Florida (Home Office:...
...June 3 On June 7, 2008 the Philadelphia,Physician...hensive,physicals for student athletes in the Phil...sylvania are required to receive a physical to be ...life-threatening conditions., The 2008 program wi...
Other Medicine News:Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 2Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 3Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 4Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 2Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 3Health News:Philly's Top Doc's Organize to Help Prevent Young Athlete Deaths in Philadelphia 2
(Date:12/2/2009)..., PLEASANTON, Calif., Dec. 2 /PRNewswire-FirstCal... today that the United States Food & Drug Admi...se for its licensed nucleic acid test, to screen s...dual donations. The test, called the cobas® T...tem, is a qualitative, in-vitro test for the simul...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswire/...ing a late-breaking presentation on Tasigna® ...yeloid leukemia, demonstrate the strength of the c...e of patients. ,, The new data, at the 51st Am...and Exposition, highlight the company,s current th...
(Date:12/1/2009)..., REDONDO BEACH, Calif., Dec. 1 Re...their Elective Single Embryo Transfer (eSET) Encou...for patients with good embryo quality and a good p...ce of twins by transferring a single embryo. ,,...logy today is reducing the number of multiple preg...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Dr Smith Comes to Washington 3A Angry Physicians From All 50 States Rally in DC on Sept 10 56422 1Dr Smith Comes to Washington 3A Angry Physicians From All 50 States Rally in DC on Sept 10 56422 2Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 56420 1Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 56420 2
...all at 9:00 AM ET Today , , CORAL GABLES, Fla.,...asdaq: CPRX ) today announced top-line results f...ine addiction. The data from the trial showed tha...ance in the primary endpoint -- that a significant...han placebo-treated subjects were cocaine-free dur...
...nd Evidence of Biological Activity in 9 of 12 Pati...7 Leading U.S. Medical Centers , , SAN DIEGO, May...data from the Calcium Up-Regulation by Percutaneou...e (CUPID), a First-in-Human Phase 1/2 Clinical Tri...merican Society of Gene Therapy Meeting. , , Th...
Other Medicine Technology:Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 2Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 3Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 4Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 2Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 3Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 4
...ual acuity system allows you access to the most po...s 10 different optotypes, crowding bars, random se...d characters. Random character sequencing eliminat...gle letter, single line and multiple line selectio...
...ght Probes provide the surgeon with an indirect il...e to be easily visualized through the laser micros...catter technique, the surgeon can enhance visualiz...ap edge folds, corneal flap striae and flap alignm...
...ual acuity system allows you access to the most po...s 10 different optotypes, crowding bars, random se...d characters. Random character sequencing eliminat...gle letter, single line and multiple line selectio...
...channel sleep diagnostic collection software. Sand...eep diagnostic collection software offers customiz...t recording or post recording. The scoring display...p events including current number of events, frequ...
Medicine Products: